Ravi Paluri to Protein Kinase Inhibitors
This is a "connection" page, showing publications Ravi Paluri has written about Protein Kinase Inhibitors.
Connection Strength
0.165
-
Paluri R, Madan A, Li P, Jones B, Saleh M, Jerome M, Miley D, Keef J, Robert F. Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2019 03; 83(3):551-559.
Score: 0.165